Free Trial

Amprius Technologies (NYSE:AMPX) Stock Price Down 2.7% - Should You Sell?

Amprius Technologies logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • AMPX fell 2.7% intraday to about $20.31 on Monday with roughly 5.23M shares traded (≈39% below its average volume), leaving the stock above its 50‑day ($16.95) and 200‑day ($13.10) moving averages and with a market cap of ~$2.78B.
  • Analysts are mostly bullish—eight Buys vs. one Sell—with an average target of $19.75 and several firms recently raising targets into the $21–$22 range, giving a consensus rating of "Moderate Buy."
  • Operationally the company beat the quarter (EPS -$0.01 vs. -$0.04; revenue $25.23M) but remains unprofitable with negative margins and FY2026 guidance of -0.060 EPS, while insiders have sold heavily (2.54M shares valued at ~$42.3M in the past 90 days), a notable governance/ownership signal.
  • MarketBeat previews top five stocks to own in June.

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) shares dropped 2.7% during mid-day trading on Monday . The company traded as low as $19.81 and last traded at $20.3110. Approximately 5,230,635 shares were traded during mid-day trading, a decline of 39% from the average daily volume of 8,643,419 shares. The stock had previously closed at $20.87.

Analysts Set New Price Targets

AMPX has been the topic of a number of recent analyst reports. Weiss Ratings restated a "sell (e+)" rating on shares of Amprius Technologies in a research report on Monday, April 20th. William Blair reiterated an "outperform" rating on shares of Amprius Technologies in a research note on Friday, March 6th. Craig Hallum raised their price objective on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a "buy" rating in a research note on Friday, March 6th. Needham & Company LLC reiterated a "buy" rating and set a $20.00 price objective on shares of Amprius Technologies in a research note on Tuesday, March 10th. Finally, B. Riley Financial increased their price target on Amprius Technologies from $16.00 to $22.00 and gave the company a "buy" rating in a research note on Monday, March 9th. Eight research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Amprius Technologies has an average rating of "Moderate Buy" and an average target price of $19.75.

Check Out Our Latest Report on Amprius Technologies

Amprius Technologies Stock Performance

The business has a 50 day simple moving average of $16.95 and a 200-day simple moving average of $13.10. The stock has a market capitalization of $2.78 billion, a P/E ratio of -59.74 and a beta of 2.20.

Amprius Technologies (NYSE:AMPX - Get Free Report) last issued its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.03. The firm had revenue of $25.23 million during the quarter, compared to analyst estimates of $22.91 million. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. Equities research analysts forecast that Amprius Technologies, Inc. will post -0.03 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Steven Chu sold 155,565 shares of the firm's stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $18.50, for a total transaction of $2,877,952.50. Following the completion of the sale, the director directly owned 127,339 shares of the company's stock, valued at $2,355,771.50. This trade represents a 54.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Wen Hsuan Hsieh sold 413,146 shares of the firm's stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $18.44, for a total value of $7,618,412.24. Following the sale, the director directly owned 44,444 shares of the company's stock, valued at approximately $819,547.36. This represents a 90.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 2,539,829 shares of company stock valued at $42,323,376. 12.80% of the stock is owned by insiders.

Institutional Investors Weigh In On Amprius Technologies

Several large investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in shares of Amprius Technologies by 9.5% during the 4th quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company's stock worth $56,245,000 after acquiring an additional 616,037 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Amprius Technologies by 10.5% during the 4th quarter. Geode Capital Management LLC now owns 2,678,417 shares of the company's stock worth $21,137,000 after acquiring an additional 253,529 shares in the last quarter. State Street Corp boosted its stake in shares of Amprius Technologies by 16.6% during the 4th quarter. State Street Corp now owns 2,553,710 shares of the company's stock worth $20,149,000 after acquiring an additional 363,928 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Amprius Technologies by 113.3% during the 3rd quarter. Invesco Ltd. now owns 2,379,384 shares of the company's stock worth $25,031,000 after acquiring an additional 1,263,846 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its stake in shares of Amprius Technologies by 23.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 2,194,841 shares of the company's stock worth $17,317,000 after acquiring an additional 410,724 shares in the last quarter. 5.04% of the stock is owned by institutional investors.

Amprius Technologies Company Profile

(Get Free Report)

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amprius Technologies Right Now?

Before you consider Amprius Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.

While Amprius Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines